Why Did Private Clinics Grow So Fast After 2018 Legalization?

In November 2018, the UK government rescheduled cannabis-based products for medicinal use. For many, this felt like the dawn of a new era. For those of us working in the National Health Service (NHS)—the UK’s publicly funded healthcare system—at the time, it felt more like the start of a very long, very complicated administrative climb. To understand why private clinics exploded in popularity following this change, you have to look at the intersection of rigid clinical guidelines and the rise of digital-first healthcare.

Let’s look at why the landscape shifted so quickly, and what this means for patients looking for help today.
The 2018 Legalization: What Actually Changed?
Before 2018, cannabis was Schedule 1, meaning it had no recognized medicinal value in the eyes of the law. Following the rescheduling, specialist doctors on the General Medical Council’s (GMC) specialist register were legally allowed to prescribe cannabis-based medicines. The Medicines and Healthcare products Regulatory Agency (MHRA) began overseeing the standards for these products.

However, "legalized" is a loaded word. It didn't mean that every doctor could suddenly prescribe cannabis. It meant that very specific specialists—those treating epilepsy, multiple sclerosis, or specific types of chronic pain—could consider it as a treatment option, but Have a peek at this website https://smoothdecorator.com/how-chronic-pain-affects-daily-life-the-reality-beyond-the-surface/ only after all other licensed treatments had failed. This created an immediate, massive gap between the law’s intent and the patient’s reality.
The Access Gap: Why the NHS Said No
Here is a reality-check: The NHS operates on a foundation of evidence-based medicine that moves slowly by design. When 2018 arrived, the National Institute for Health and Care Excellence (NICE) guidelines remained extremely cautious. NICE is the body responsible for deciding what treatments the NHS pays for. Because they found a lack of large-scale clinical trial data, they advised against most cannabis-based prescriptions.

For patients who had spent years trying conventional medications with little success, this was a brick wall. This is where the access gap NHS issues became undeniable. If you were a patient in pain, you weren't looking for a debate on clinical evidence—you were looking for a way to function. When the NHS couldn't provide, patients looked https://highstylife.com/how-long-does-it-take-to-go-from-online-assessment-to-prescription/ elsewhere.
Comparison: NHS vs. Private Access Pathways Feature NHS Pathway Private Providers UK Prescription Cost Standard prescription fee Full market price (product + consultation) Speed of Access Very slow; multiple layers of referral Fast; direct-to-patient booking Doctor Availability Limited specialists Increasing pool of specialists Clinical Guidelines Strictly NICE-compliant Clinical judgment within GMC frameworks How Private Providers Filled the Void
Private clinics grew fast because they identified the two biggest problems in the current system: geography and bureaucracy. Before the proliferation of these clinics, if you wanted to see a specialist who had an interest in cannabis-based medicines, you might have had to travel across the country, sit on waiting lists for months, and deal with an overwhelming amount of paperwork.

Private clinics leveraged telehealth accessibility. By moving consultations online, they removed the physical barrier for people with chronic conditions. If you have mobility issues or chronic pain, the last thing you want to do is travel three hours to a clinic. By utilizing video consultations, private providers made the process accessible from the patient's own living room.
The Digital-First Healthcare Workflow
The speed of growth wasn't just about the medicine; it was about the workflow. These companies built digital platforms designed to be user-friendly. In my time working with patient advocacy groups, I’ve seen how transformative this can be when done correctly. The typical digital-first workflow looks like this:
Digital Screening: Patients fill out online forms detailing their medical history and current symptoms. Eligibility Check: AI-driven or administrative triage determines if the patient meets the criteria for a specialist consultation. Record Retrieval: The clinic requests a Summary Care Record (SCR) from the patient’s GP. Video Consultations: A specialist doctor conducts an assessment via a secure video link. Pharmacy Link: If prescribed, the electronic script is sent to a specialized pharmacy, and the medicine is delivered to the patient's door.
This streamlined process is a stark contrast to the traditional "GP referral to consultant, then waiting for a clinic letter, then booking an appointment" cycle that defines much of the NHS.
Things Patients Wish They Knew Before the First Video Consult
I hear from patients every week. Many enter the private sector with high expectations, hoping for an immediate turnaround. Here is what they wish they knew before their first video call:
The "Miracle" Trap: No reputable clinic will promise you a cure. If they do, leave. These are medicines for symptom management, not a magic switch. Your GP is Still Your GP: A private prescription does not replace your GP. You must keep your regular doctor informed, as they need to manage your other health needs. The Cost of Maintenance: It’s not just the first consultation. You need follow-ups to maintain the prescription. Factor in the monthly cost of the medicine, which is currently not subsidized by the government. The "Medical vs. Recreational" Confusion: Be prepared to answer questions about your history honestly. These doctors are regulated. They are looking for clinical necessity, not just a reason to sign a script. Evidence is Mandatory: Have your medical records and a history of previous medications ready. If you haven't "failed" traditional treatments, you are unlikely to be prescribed cannabis-based medicine. The Reality of Telehealth Accessibility
While the growth of private clinics has been a lifeline for thousands, we have to talk about the reality of telehealth accessibility. While video consultations make things easier for some, it creates a digital divide for others. Older patients or those without reliable internet access are often left behind by this "digital-first" model. Furthermore, the reliance on private income means that your access to care is determined by your bank account, which is a significant point of contention in the UK.

When I talk to clinic staff, I often ask what keeps them up at night. The answer is usually the same: the fear of over-regulation based on the poor behavior of a few bad actors. They are under immense pressure to prove that their clinical standards are just as high as those in the NHS, even though they aren't working within the same funding structures.
Final Thoughts: Where Are We Now?
The rapid growth of private clinics since 2018 is a symptom of a healthcare system struggling to adapt to modern patient needs. We are seeing a move toward a model where the patient is the driver of their own care journey, facilitated by technology. However, we have a long way to go before this becomes an equitable system for everyone in the UK.

Here is what usually happens next for the industry: we are likely to see more scrutiny from regulators like the Care Quality Commission (CQC) to ensure that digital clinics aren't cutting corners. We are also likely to see more integration between private providers and NHS electronic record systems, which will help keep primary care doctors in the loop.

If you are considering a private pathway, do your homework. Check if the clinic is CQC-registered, look for specialist doctors who are on the GMC register, and most importantly, keep your expectations grounded in the clinical reality of your specific condition. You are looking for a service that prioritizes patient safety over high-speed volume—and those are the providers that will stand the test of time.